Titan Spine, a privately-owned medical implant surface technology company that designs and manufactures proprietary interbody fusion devices for the spine, has received CE mark to commercially release its line of Endoskeleton lumbar interbody fusion devices in Europe.

The implants which consist of the Endoskeleton TA (ALIF), Endoskeleton TT (TLIF), and Endoskeleton TO (PLIF and Oblique) feature a roughened titanium surface topography that is designed to promote rapid bony integration and subsequent fusion.

Titan Spine president Kevin Gemas said in addition, they plan to obtain CE mark certification for cervical product line in the near future to further increase their addressable market in Europe.

Titan Spine Senior Quality Assurance & Regulatory Affairs director Scott Van Ells said the flexibility in allowing for a dynamic exchange of ideas to ensure that all domestic regulatory requirements are maintained while including additional requirements for the European Union was vital to the success of this project.